Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
The Ensign Group
ENSG
$10.5B
| $22.3M | 0.01% |
127,998
-8,242
| -6% | -$1.48M |
|
1202
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $22.2M | 0.01% |
676,367
-466,881
| -41% | -$15.3M |
|
1203
Sprouts Farmers Market
SFM
$7.87B
| $22.2M | 0.01% |
278,372
-308,752
| -53% | -$27.7M |
|
1204
BILL Holdings
BILL
$4.93B
| $22.2M | 0.01% |
406,503
-11,152
| -3% | -$573K |
|
1205
PUT
Bath & Body Works
BBWI
$3.81B
| $22.1M | 0.01% |
1,103,000
-2,819,700
| -72% | -$62.3M |
|
1206
Huntsman Corp
HUN
$1.83B
| $22.1M | 0.01% |
2,208,925
+1,573,730
| +248% | +$14.4M |
|
1207
TransUnion
TRU
$15.4B
| $22.1M | 0.01% |
257,449
-76,547
| -23% | -$6.29M |
|
1208
CALL
Macy's
M
$6.45B
| $22.1M | 0.01% |
1,000,000
-500,000
| -33% | -$10.2M |
|
|
PSKY
1209
Paramount Skydance Corp
PSKY
$10.5B
| $21.9M | 0.01% |
1,632,906
-12,013,798
| -88% | -$188M |
|
1210
Cytokinetics
CYTK
$10.6B
| $21.8M | 0.01% |
343,458
-54,617
| -14% | -$3.4M |
|
1211
CALL
J.M. Smucker
SJM
$12.5B
| $21.8M | 0.01% |
222,600
| – | – |
|
|
GAP
1212
PUT
The Gap Inc
GAP
$7.55B
| $21.8M | 0.01% |
850,100
-122,500
| -13% | -$2.97M |
|
1213
LivaNova
LIVN
$4.33B
| $21.7M | 0.01% |
353,228
-31,573
| -8% | -$1.8M |
|
1214
Credicorp
BAP
$30B
| $21.7M | 0.01% |
75,699
-89,562
| -54% | -$23.7M |
|
1215
CALL
Apollo Global Management
APO
$82.8B
| $21.7M | 0.01% |
150,000
-9,000
| -6% | -$1.2M |
|
1216
American Homes 4 Rent
AMH
$12.2B
| $21.7M | 0.01% |
675,906
+172,113
| +34% | +$5.52M |
|
1217
PUT
Jefferies Financial Group
JEF
$12.7B
| $21.7M | 0.01% |
+350,000
| New | +$20.1M |
|
1218
Dycom Industries
DY
$12.1B
| $21.6M | 0.01% |
64,010
+7,908
| +14% | +$2.49M |
|
1219
CALL
Papa John's
PZZA
$801M
| $21.6M | 0.01% |
+561,800
| New | +$24.8M |
|
1220
PUT
ResMed
RMD
$32.6B
| $21.6M | 0.01% |
89,500
+82,500
| +1,179% | +$21.1M |
|
1221
XPeng
XPEV
$11.4B
| $21.5M | 0.01% |
1,060,869
+840,874
| +382% | +$18.2M |
|
1222
Check Point Software Technologies
CHKP
$13.2B
| $21.5M | 0.01% |
115,880
+39,967
| +53% | +$7.73M |
|
1223
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.56B
| $21.5M | 0.01% |
592,205
+18,337
| +3% | +$665K |
|
1224
iPath Series B S&P 500 VIX Mid-Term Futures ETN
VXZ
$30.6M
| $21.4M | 0.01% |
400,526
| – | – |
|
1225
Houlihan Lokey
HLI
$8.77B
| $21.4M | 0.01% |
122,900
-106,175
| -46% | -$19.5M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.